Gossamer Bio Inc

NASDAQ:GOSS 4:00:00 PM EDT

0.94

-0.02 (-2.40%)

6:30:48 PM EDT: $0.94 0.00 (-0.40%)

Market Cap (Intraday)	213.07M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$8.53 Million
Adjusted EPS	-$0.15

See more estimates

10-Day MA	$0.99
50-Day MA	$0.92
200-Day MA	$0.94

See more pivots

Gossamer Bio Inc Stock, NASDAQ:GOSS

3013 Science Park Road, Suite 200, San Diego, California 92121

United States of America

Phone: +1.858.684.1300

Number of Employees: 135

http://www.gossamerbio.com

Description

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi in 2015 and is headquartered in San Diego, CA.